Asosiy kontentga oʻtish
Maqola

Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy

Guru SonpavdeUS Oncology Research, Inc., Houston, TX; Texas Oncology PA, Webster, TX. Electronic address: [email protected]Phillip PerimanUS Oncology Research, Inc., Houston, TX; Texas Oncology PA, Amarillo, TXD. M. BernoldUS Oncology Research, Inc., Houston, TX; Interlakes Oncology Hematology, Rochester, NYDouglas WecksteinUS Oncology Research, Inc., Houston, TX; New Hampshire Hematology-Oncology, P.A., Hooksett, NHMark T. FlemingUS Oncology Research, Inc., Houston, TX; Virginia Oncology Associates, Hampton, VAMatthew D. GalskyComprehensive Cancer Centers of Nevada, Las Vegas, NVWilliam R. BerryUS Oncology Research, Inc., Houston, TXFeng ZhanUS Oncology Research, Inc., Houston, TXKristi A. BoehmUS Oncology Research, Inc., Houston, TXLina AsmarUS Oncology Research, Inc., Houston, TXThomas E. HutsonUS Oncology Research, Inc., Houston, TX; Baylor Sammons Cancer Center, Dallas, TX, USA
2009en
ABI

Annotatsiya

Annotatsiya mavjud emas.

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba